Question · asked by 0 reviews

Enamel matrix derivative (EMD; Emdogain) vs Open flap debridement / control flap surgery (placebo vehicle gel in three trials): Tooth loss

Population
Patients affected by periodontitis, with intrabony defects to be treated
Intervention
Enamel matrix derivative (EMD; Emdogain)
Comparison
Open flap debridement / control flap surgery (placebo vehicle gel in three trials)
Outcome
Tooth loss

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Enamel matrix derivative (EMD; Emdogain) vs Open flap debridement / control flap surgery (placebo vehicle gel in three trials)
Tooth loss · Patients affected by periodontitis, with intrabony defects to be treated · 1 year (18-month data used for one trial)
Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects (2003) · Cochrane All outcomesearlier version CD003875, superseded
There were insufficient numbers of teeth lost to undertake an analysis; all four teeth removed (two control, two test) were extracted for prosthetic reasons (Heijl 1997).8 studiesGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects
2009 · Cochrane All outcomes
2009-02Not listedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.